Inking $13.4M Series E, VisionCare Adds to Board
VisionCare Ophthalmic Technologies Inc. recently closed on $13.4 million in Series E financing and added venture capitalist Elka Nir to its board. Nir heads life science investments for Tel Aviv-based Giza Venture Capital. Saratoga, Calif.-based VisionCare develops devices designed to improve vision for individuals with untreatable retinal disorders.
7 February 2011•3 mins read
